OBJECTIVE: Allergic disease is multifactorial in origin. Because iron nutrition affects immune responses and maternal pregnancy weight gain impairs fetal iron delivery while increasing fetal demands for growth, the study examined maternal pregnancy weight gain, newborn iron status and an index of atopic disease, infant eosinophilia. STUDY DESIGN: Within a larger prospective study of healthy newborns at risk for developing iron deficiency anemia, umbilical cord iron indicators were compared to infant eosinophil counts. RESULT: Infants who developed eosinophilia exhibited higher cord reticulocyte-enriched zinc protoporphyrin/heme ratio, Po 0.05 and fewer cord ferritin values in the highest (best) quartile, P o 0.05. If cord ferritin was in the upper three quartiles, the negative predictive value for infant eosinophilia was 90%. High maternal pregnancy weight gain predicted infant eosinophil counts, P o 0.04, and contributed to cord ferritin predicting eosinophilia, P o 0.003. CONCLUSION: Poor fetal iron status may be an additional risk factor for infant eosinophilia.
INTRODUCTION
Risk for poor iron status and atopic disease may overlap in some infants, including those born to mothers with a history of gestational obesity.
1,2 Obesity during pregnancy and higher pregnancy weight gain have been shown to lessen the placental transfer of maternal iron, increase iron needs for fetal growth and impair fetal erthyrocyte and tissue iron allotment. 3, 4 Maternal pregnancy weight gain is also associated with increased risk for childhood asthma 5 and dysregulated cord blood immune responses, 6 but the mechanism behind this association is unknown.
Persistent blood eosinophilia is a recognized hematological correlate of recurrent wheeze [7] [8] [9] [10] because it reflects inflammatory pathways involved in the pathogenesis of atopic disease. 1, 11, 12 The maturation, recruitment and activation of eosinophils originates from a relative overproduction of certain cytokines from allergic T-helper (Th) type 2 (Th2) lymphocytes. 11, 12 Iron is essential for Th cell maturation 2, [13] [14] [15] and the relative amount of cellular iron needed for non-allergic Th type 1 (Th1) lymphocytes is greater than for Th2. In vitro work found compromised Th1 proliferation and cytokine production under iron-limited conditions, 16 but unchanged clonal growth and cytokine production in Th2 cells. Poor iron availability during the development of the fetal immune system may consequently result in a pattern of persistent Th2 dominance. The finding of low umbilical cord iron content associated with wheezing in later infancy supports this connection between early iron status and future atopic disease. 17 Although typically considered to be distinct pediatric outcomes, the goal of the current analysis was to investigate the linkage between the potential impact of higher maternal pregnancy weight gain, iron status at birth and eosinophilia in infancy. The conceptual framework for our hypothesis-generating investigation is that impaired fetal iron biology, influenced by maternal weight gain, can affect immune regulation and predispose for atopic airway disease in childhood.
METHODS

Eligibility and enrollment
This prospective, observational study examined newborns with prenatal risk factors for the development of infant iron deficiency anemia (IDA) and was approved by the institutional review boards at the University of Wisconsin, Madison and Meriter Hospital. Newborns with one or more of the following risk factors for infant IDA were recruited for enrollment: prenatally diagnosed maternal IDA, pre-gestational or gestational diabetes mellitus, small-for-gestational age or large-for-gestational age newborns, maternal ethnic minority (African American, Latina or Asian) or low socioeconomic status using the surrogate indicator of self-pay or Wisconsin Medicaid. 3, 4 English-and Spanish-speaking women 18 to 40 years of age delivering infants ⩾ 35 weeks of gestation at the Meriter Hospital Birthing Center were approached for written consent. This study screened 210 enrollees with umbilical cord clamping occurring immediately (o 30 s) after birth, and not via delaying clamping ⩾ 30 s, a method known to improve iron status. Although all 210 immediate clamped enrollees had cord blood iron assessments, 97 were used here due to availability of eosinophil counts by 12 months of age.
Electronic medical record examination
Electronic medical records were examined for newborn birth weight and length, gestational age, sex or delivery method. Maternal age, anemia, prenatal vitamin use, diabetes, pregnancy complications, body mass index (BMI), maternal pregnancy weight gain, insurance status, education, race/ethnicity and personal and/or family history of atopic disease or asthma were also recorded at delivery. During the first year of life, the infant's physician performed physical assessments and determined characteristics known to be associated with atopic airway disease. Infant weight and length, duration of breastfeeding, daycare status, number of siblings, respiratory and total infections, wheezing episodes, ER/urgent care visits for wheezing and inhaled beta agonist and systemic steroid therapy were recorded at 6 and/or 12 months of age.
Sample collection and laboratory tests
Blood collected from the umbilical cord was stored at 4°C and processed within 8 days of collection. Blood was also collected from older infants at 6 and 12 months. Cord and infant iron indices were determined, including hemoglobin (Hb) and mean cell volume by pocH-100i analyzer (Sysmex, Mundelein, IL, USA). Red blood cell iron incorporation was tested by zinc protoporphyrin/heme ratio (ZnPP/H) and reticulocyte-enriched ZnPP/H (RE-ZnPP/H), (Hemafluorometer, Aviv Biomedical, Lakewood, NJ, USA).
18
Δ-ZnPP/H (ΔZnPP/H) was defined as the difference between RE-ZnPP/H and whole blood ZnPP/H. 18 Storage iron was assessed by plasma ferritin test (Bio-Quant ELISA, San Diego, CA, USA). Infant blood was additionally tested for total white blood cell and lymphocyte counts (pocH-100i analyzer, Sysmex), and eosinophil percentages were determined by a blinded reviewer on Wright-Giemsa-stained smears. From these measures, absolute eosinophil counts were calculated. Cord blood eosinophils were not counted due to potential artifactual lowering of counts after 1 week of storage.
Data analysis
Demographic and laboratory data were initially analyzed by the presence and absence of eosinophilia in infancy. Absolute eosinophilia ⩾ 470 × 10 6 l − 1 was used as the criterion for eosinophilia because it more accurately represents eosinophilia than does a percentage, 9, 10 and was previously shown to predict persistent wheezing in infants. 19 Low cord ferritin was defined as the lower 25th percentile (⩽84 μg l − 1 ) and upper 25th percentile (4200 μg l − 1 ), 20 and low infant ferritin as ⩽ 11 μg l − 1 . Data were also dichotomized by maternal pregnancy weight gain, and dichotomized as o 18 kg (normal) or ⩾ 18 kg (maximal recommended weight gain for any pregnancy). 21 Unpaired t-tests were used for normally distributed data and log-converted plasma ferritin. Mann-Whitney U-tests, chi-square, simple linear regression, analysis of variance and multiple analysis of variance tests were also used. Values are portrayed in the tables as mean ± s.e. A P-value of o0.05 was set for attaining statistical significance. The primary end point for ascertaining IDA during infancy was a composite outcome of lowest Hb at 6 or 12 months of age, because if abnormal iron status was found at 6 months, iron treatment was initiated at 6 months. Likewise, the lowest plasma ferritin or highest ZnPP/H values at 6 or 12 months were secondary study end points, because of the impact of treatment. The highest eosinophil count at 6 or 12 months and corresponding white blood cell and lymphocyte counts have been reported.
RESULTS
Maternal and neonatal demographics at birth
Eosinophil counts were determined by 12 months of age in 97 enrollees. Thirteen enrollees (13%) had eosinophilia during infancy. No differences in birth weight, Z-score, BMI, gestational age, gestational size (appropriate, small or large), sex or delivery method were found between those presenting or not presenting with eosinophilia (Table 1) . Maternal age, weight, anemia, prenatal vitamin use, diabetes, pregnancy conditions, insurance status, education, race/ethnicity or personal and/or family history of atopic disease or asthma did not reveal a difference between those with and without eosinophilia ( Table 1) .
Laboratory tests at birth Cord RE-ZnPP/H, reflecting iron incorporation in reticulocytes, was 34% higher in those who would develop eosinophilia, P o 0.05 (Table 2 ). In addition, cord ΔZnPP/H was 2.5-fold higher in those with eosinophilia, Po 0.01. However, the general ZnPP/H values in the cord blood were not linearly related to later eosinophil counts, nor were Hb and ferritin levels, until criterion values were employed. When the distribution of plasma ferritin values was considered, significantly fewer infants with eosinophilia had been born with ferritin in the upper quartile range (4200 μg l ), resulted in a 25% positive predictive value for eosinophilia developing by 1 year of age. Taking into account a familial history of prior atopic airway disease, the negative predictive value of cord ferritin values in the three upper quartiles rose to 94% and the positive predictive value for newborns in the lowest quartile to 38.5% for eosinophilia by 1 year. In multivariate analysis, a significant interaction was found between low cord ferritin and history of maternal allergic airway disease, F 2,88 = 4.02, P o 0.05. Abbreviations: AA, African American; AGA, appropriate-for-gestational age; BMI, body mass index; C/S, cesarean section; L, Latina;
LGA, large-for-gestational age; O, other; SGA, small-for-gestational age; W, white.
Iron at birth and eosinophila
Characteristics of atopic disease in infancy No relationship was found between infant eosinophilia and 12-month weight, number of siblings, number respiratory or total infections, recurrent wheezing or ER visits for wheeze in the first year of life (Table 3 ). There were also no differences in betaagonist use. However, in those with eosinophilia, the number of systemic steroid therapy for allergic airway disease was sevenfold higher, P o 0.008, and the percentage of infants receiving systemic steroid therapy for allergic airway disease was 4.5-fold higher, P o0.003 (Table 3) . Breastfeeding duration averaged 3.1 months longer in the eosinophilia group, P o 0.05 (Table 3) . Two other laboratory values also supported the presence of generalized inflammation during infancy (Table 4) . Infants who developed eosinophilia, the total white blood cell count was 18% higher, P o0.04, and lymphocyte count was 24% higher, P o 0.02. Infant iron measures and timing of any of the supplemental iron source (either cereal, iron supplements or formula) did not differ by eosinophil group, although many infants from both groups exhibited low Hb or plasma ferritin, or high ZnPP/H. 22 In addition, when grouping by high or low ferritin either at birth or in infancy, timing of the supplemental iron source did not differ by group.
Obese environment during gestation Mothers who exceeded the maximum recommended pregnancy weight gain 21 were more likely to have infants with elevated eosinophil counts, Po 0.04, as well as to birth neonates with higher cord Hb, higher cord RE-ZnPP/H and lower cord ferritin, Iron at birth and eosinophila R Weigert et al Po 0.05. Weight gain was associated with higher maternal and neonatal BMI values, and with the larger infant BMI still evident at 6 and 12 months, P o0.05. Furthermore, women exceeding recommended pregnancy weight gain had infants with higher white blood cell counts, P o0.04 and lymphocyte counts, P o 0.02. The relative effect on eosinophilia was examined in a multivariate analysis and demonstrated that cord iron status rather than excessive gestational weight gain was a better predictor of later eosinophilia, F 2,78 = 4.0, P o0.05, and there was not a significant interactive effect of weight gain and neonatal iron level (Table 5) .
DISCUSSION
The burden of pediatric atopic disease and asthma is substantial, 23 impacting well over 10% of all children in the US, and a disproportionately high percentage in children of minority status. 24 Although familial factors contribute to atopic disease or wheezing risk, inheritance accounts for less than one-third of cases. 25 Thus there is a need to understand other processes involved in the cascade of events leading to allergy and the airway hyperresponsiveness. Our parent study of a larger cohort of infants at risk for developing IDA found that excessive maternal pregnancy weight gain was associated with poorer fetal iron status and an inflammatory bias at birth. 4 Iron is known to be essential for the normal immune development, 2,13,14,15 which led us to consider the linkage between an obese in utero environment, iron status and allergic airway disease: perinatal and pediatric conditions normally viewed as distinct. Although not population-based research, it revealed an association between poor iron status at birth and the likelihood of developing eosinophilia, an accepted clinical marker of allergic disease. Eosinophilia is one of the several commonly employed risk indices for allergies and asthma 7, 8, 9, 10 with improved predictive utility when persistent. 8, 9, 26 Infants with eosinophilia in our study were more likely to be prescribed systemic steroidal medications for allergic airway disease, indicative of more symptomatic airway disease. Although we found that maternal weight gain during pregnancy may impact the likelihood of eosinophilia, iron status predominated in defining this relationship. With respect to the healthy, unaffected infants, sufficient iron status at birth emerged as a negative predictor for eosinophilia.
Thus, both with respect to the compromised newborn as well as for the ones with sufficient iron stores, iron status may help to explain one of the mediating pathways from the prenatal environment to allergic disease.
Iron delivery to the fetus is normally proportional to fetal weight. Thus the combination of normal ZnPP/H and higher reticulocyte ZnPP/H in infants prone to eosinophilia supports a time-sensitive, late gestational linkage. Lower fetal storage iron coincided with the massive perinatal lymphocyte expansion reinforces this temporal relationship. Clinically, iron status is not normally assessed at birth, but more typically later in infancy when our study found iron status no longer differed between infants with and without eosinophilia. In the current study, timing of any supplemental iron source did not differ by eosinophil group, supporting similar postnatal iron supply. It is possible that a limited iron supply at a critical perinatal window during the T cell maturation that accompanies the perinatal lymphocyte expansion may be more critical for programming long-term function than contemporaneous iron supply at 1 year of age. It is known that when fetal iron supply is limited, iron is prioritized to the erythrocyte at the expense of other vital developing tissues. 27 This prioritization may compromise the vulnerable Th1 lymphocyte clones that have previously been shown to have lower intracellular iron stores. A developmental programming window for lymphocyte function is consistent with previous findings demonstrating different cytokine patterns at birth for infants predisposed to atopic disease. 28, 29 A recently published study found a relationship between maternal iron status, pulmonary function and reactive airways in her offspring, 30 and the current study extends these findings by reporting a relationship between fetal iron status and eosinophilia. We did not observe a relationship between iron and eosinophilia in later infancy, when growth rate, dietary factors and infant absorptive ability can impact infant iron status. However, this question should be studied in a larger cohort to determine the critical developmental window that programs an allergic predisposition.
Maternal atopic disease was common, but in the multivariate analysis, did not emerge as an independent predictor of infant eosinophilia. Instead this factor appeared to have a summative influence along with neonatal iron status. Inflammatory processes in women with atopic conditions and asthma during pregnancy Iron at birth and eosinophilacould negatively impact fetal iron supply through impaired placental iron transfer. In addition, it is known that maternal obesity during pregnancy increases fetal growth rate and thus iron demand. We have reported previously that obesity during gestation and higher maternal pregnancy weight gain, both inflammatory processes, are linked to poorer cord iron status. 4 In another large cohort, Halonen et al. 6 reported that excess pregnancy weight gain was associated with childhood asthma. Studies have also shown that in non-pregnant older adults, rapid weight gain increases inflammation. 31, 32 Obesity and diabetes during pregnancy may thus have proinflammatory effects while simultaneously reducing placental iron transfer and increasing iron demands due to augmented fetal growth. 3, 33, 34 Of interest, the infants in our cohort born after pregnancies with higher maternal weight gain were not only larger at birth, but also continued to have larger BMIs at 6 and 12 months of age. Given the current prevalence of maternal and childhood obesity, the significance of these associations between excessive growth, iron utilization and proinflammatory reactions will continue to have clinical significance. It may also be possible to employ novel preventative strategies, such as delayed umbilical cord clamping, which can improve erythrocyte mass through provision of considerable blood volume, and thus iron endowment for meeting the iron needs during immediate postnatal life. Iron administration can reduce airway hyperreactivity and eosinophilia in animal studies. 28, 29 Our findings should be replicated and extended in a larger cohort, because they are limited by a small number of infants with eosinophilia by 1 year of age and an inability to follow this cohort further into childhood. Although preliminary, the results bring to light a novel relationship between low iron at birth and greater risk for later atopic disease. Clinicians should be aware that a history of high maternal weight gain may predispose infants to low iron at delivery and increase the risk for developing atopic disease.
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